Journal Basic Info
- Impact Factor: 0.285**
- H-Index: 6
- ISSN: 2638-4558
- DOI: 10.25107/2638-4558
Major Scope
- Physical Medicine & Rehabilitation
- Orthopedic Sugery
- Dentistry and Oral Medicine
- Family Medicine and Public Health
- Veterinary Sciences
- Infectious Disease
- Chemotherapy
- Psychiatry
Abstract
Citation: Clin Case Rep Int. 2023;7(1):1636.DOI: 10.25107/2638-4558.1636
A Case Report of Nasopharyngeal Neuroendocrinen Carcinoma
Sun L, Zhao L and Chen W
Qingdao Hospital, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital), China
PDF Full Text Case Report | Open Access
Abstract:
Background: The purpose of this article is to report the treatment outcome of a patient with nasopharyngeal neuroendocrine carcinoma. Method: The patient received concurrent Chemoradiotherapy (CRT) for the primary lesion and microwave ablation for isolated hepatic metastasis later. Results: Complete Remission (CR) was achieved after the completion of concurrent CRT. However, Prophylactic Cranial Irradiation (PCI) was not performed. Isolated hepatic metastasis was diagnosed 3 months after the completion of CRT. Then microwave ablation for isolated hepatic metastasis was performed cc. Finally, unlike the most common death caused by brain metastasis in literature retrieval, the patient died of hepatic function failure caused by multiple hepatic metastasis. The Overall Survival (OS) of the patient is about 18 months. Conclusion: Standardized concurrent CRT also has a good therapeutic effect on nasopharyngeal neuroendocrine carcinoma. The administration of prophylactic cranial irradiation may not be necessary for nasopharyngeal neuroendocrine carcinoma, which remains to be confirmed.
Keywords:
Nasopharyngeal carcinoma; Neuroendocrine tumors; Concurrent chemoradiation; Prophylactic cranial irradiation
Cite the Article:
Sun L, Zhao L, Chen W. A Case Report of Nasopharyngeal Neuroendocrine Carcinoma. Clin Case Rep Int. 2023; 7: 1636.